SynopsisThe global Biochips (Microarrays & Microfluidics) market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. Following a strong growth of 26.2 percent in the year.....
Synopsis The global Biotextiles market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market for Biotextiles is estimated to increas.....
SynopsisThe global Bladder Cancer market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market for Bladder Cancer is estimated to increase from $ mill.....
SynopsisThe global Cardiac Assist Devices (CAD) market was valued at US$ 1260 million in 2023 and is anticipated to reach US$ 1582 million by 2030, witnessing a CAGR of 3.3% during the forecast period 2024-2030. Chronic Obstructive Pulmonary Disease (COPD) is a .....
Synopsis The global Celiac Disease market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market for Celiac Disease is estimated to i.....
SynopsisThe global Cell Line Development Services market was valued at US$ 1678.4 million in 2023 and is anticipated to reach US$ 2542.3 million by 2030, witnessing a CAGR of 6.2% during the forecast period 2024-2030. North American market for Cell Line Developm.....
SynopsisThe global Cell-Free DNA (cf-DNA) Testing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. Cell-free DNA (cfDNA) testing, also known as non-invasive pre.....
SynopsisThe global Chronic Kidney Disease (CKD) market was valued at US$ 88540 million in 2023 and is anticipated to reach US$ 111810 million by 2030, witnessing a CAGR of 3.3% during the forecast period 2024-2030. Chronic Obstructive Pulmonary Disease (COPD) is.....
SynopsisThe global Chronic Obstructive Pulmonary Disorder (COPD) market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. Chronic Obstructive Pulmonary Disease (COPD) i.....
SynopsisThe global Colon & Rectal Carcinoma market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market for Colon & Rectal Carcinoma is estimated to .....